SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Avitar AVR:AMEX -- Ignore unavailable to you. Want to Upgrade?

To: sandintoes who wrote (13)12/22/2004 11:56:44 AM
From: country bob  Respond to of 58
 
A few PR's back they announced that they will start distributing the Drug-O-Meter en masse in early January. Even if it is only used as a preliminary test, it will save businesses and law enforcement a ton of money. Companies lie Lowes, Home Depot, and Wal Mart would save over $100 per job application alone! This should prove to be Avitar's claim to fame. Obviously they have the AMEX convinced, or they would have been de-listed a year ago. Anyway, that's MY take on the company.



To: sandintoes who wrote (13)12/22/2004 12:11:41 PM
From: country bob  Read Replies (1) | Respond to of 58
 
Volume is up again so far today and the trades are averaging 38,000+ shares each. I doubt very much that anybody would bother to daytrade it with such a small swing in the pps, so it appears to be legitimate interest. My only concern is that their marketing dept. needs to be a little bit more on the ball than their PR dept.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News